{"title":"Eltrombopag成功治疗2例儿童难治性免疫性血小板减少性紫癜","authors":"B. Yılmaz","doi":"10.19080/ajpn.2018.07.555758","DOIUrl":null,"url":null,"abstract":"Immune thrombocytopenic purpura (ITP) is an acquired autoimmune disorder that affects children and adults. It is characterized by isolated thrombocytopenia with a peripheral blood platelet count < 100x109/L, and all other secondary causes must be excluded [1]. Definition of newly diagnosed ITP; within three months from diagnosis, persistent ITP; between three to 12months from diagnosis, chronic ITP; when the disease lasts for more than 12months [2].","PeriodicalId":93160,"journal":{"name":"Academic journal of pediatric and neonatology","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2018-07-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Successful Treatment of Two Children’s with Refractory Immune Thrombocytopenic Purpura with Eltrombopag\",\"authors\":\"B. Yılmaz\",\"doi\":\"10.19080/ajpn.2018.07.555758\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Immune thrombocytopenic purpura (ITP) is an acquired autoimmune disorder that affects children and adults. It is characterized by isolated thrombocytopenia with a peripheral blood platelet count < 100x109/L, and all other secondary causes must be excluded [1]. Definition of newly diagnosed ITP; within three months from diagnosis, persistent ITP; between three to 12months from diagnosis, chronic ITP; when the disease lasts for more than 12months [2].\",\"PeriodicalId\":93160,\"journal\":{\"name\":\"Academic journal of pediatric and neonatology\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2018-07-10\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Academic journal of pediatric and neonatology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.19080/ajpn.2018.07.555758\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Academic journal of pediatric and neonatology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.19080/ajpn.2018.07.555758","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Successful Treatment of Two Children’s with Refractory Immune Thrombocytopenic Purpura with Eltrombopag
Immune thrombocytopenic purpura (ITP) is an acquired autoimmune disorder that affects children and adults. It is characterized by isolated thrombocytopenia with a peripheral blood platelet count < 100x109/L, and all other secondary causes must be excluded [1]. Definition of newly diagnosed ITP; within three months from diagnosis, persistent ITP; between three to 12months from diagnosis, chronic ITP; when the disease lasts for more than 12months [2].
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
